American journal of cardiovascular drugs : drugs, devices, and other interventions

Keyphrases

Publications

volume 24, number 4, 2024

Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Yong Wan, Shuai He, Shasha Wang, Tingli Xu, Minfang Qi, Pengcheng Gan
Efficacy and Safety of Interleukin-1 Inhibitors in the Management of Patients with Recurrent Pericarditis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, Beatrice Simeone, Maurizio Forte, Luca D'Ambrosio, Matteo Betti, Alessandra D'Amico, Vittoria Cammisotto, Roberto Carnevale, Simona Bartimoccia, Pierre Sabouret, Giuseppe Biondi Zoccai, Giacomo Frati, Valentina Valenti, Sebastiano Sciarretta, Erica Rocco
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, Beatrice Simeone, Maurizio Forte, Luca D'Ambrosio, Matteo Betti, Alessandra D'Amico, Vittoria Cammisotto, Roberto Carnevale, Simona Bartimoccia, Pierre Sabouret, Giuseppe Biondi Zoccai, Giacomo Frati, Valentina Valenti, Sebastiano Sciarretta, Erica Rocco
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Dimitrii Khelimskii, Ivan Bessonov, Stanislav Sapozhnikov, Aram Badoyan, Aleksey Baranov, Mahmudov Mamurjon, Serezha Manukian, Ruslan Utegenov, Oleg Krestyaninov
Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Yue Chen, Mengdi Wang, Yali Yang, Min Zeng
Efficacy and Safety of Alprostadil in Microcirculatory Disturbances During Emergency PCI: A Meta-Analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Hong-Fei Wang, Yu-Cheng Mao, Su-Fen Qi, Xin-Yi Xu, Zi-Yan Zhang, Chang Geng, Kai Song, Qing-Bao Tian
Benefits and Risks of Antihyperlipidemic Medication in Adults with Different Low-Density Lipoprotein Cholesterol Based on the Number Needed to Treat. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Taha Mansoor, Subaina N Khalid, Muhammad Ibraiz Bilal, Sardar Hassan Ijaz, Marat Fudim, Stephen J Greene, Haider J Warraich, Vijay Nambi, Salim S Virani, Gregg C Fonarow, Dmitry Abramov, Abdul Mannan Khan Minhas
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Yong Wan, Shuai He, Shasha Wang, Tingli Xu, Minfang Qi, Pengcheng Gan
Efficacy and Safety of Interleukin-1 Inhibitors in the Management of Patients with Recurrent Pericarditis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Hussain Sohail Rangwala, Hareer Fatima, Mirha Ali, Muhammad Ashir Shafiq, Burhanuddin Sohail Rangwala, Vikash Virwani, Aashish Kumar, Syed Ali Arsal, Adarsh Raja, Sandesh Raja, Muhammad Saqlain Mustafa
Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Gustavo de Oliveira Almeida, Thiago Faraco Nienkötter, Caroline Cristine Almeida Balieiro, Eric Pasqualotto, Júlia Braga Cintra, Henrique Champs Porfírio Carvalho, Ana Laura Soares Silva, Júlia Camargo Kabariti, Bárbara Silvestre Minucci, Edmundo Damiani Bertoli, Camila Mota Guida
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Teresa Vezza, Víctor Manuel Víctor
Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Taha Mansoor, Subaina N Khalid, Muhammad Ibraiz Bilal, Sardar Hassan Ijaz, Marat Fudim, Stephen J Greene, Haider J Warraich, Vijay Nambi, Salim S Virani, Gregg C Fonarow, Dmitry Abramov, Abdul Mannan Khan Minhas
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Yue Chen, Mengdi Wang, Yali Yang, Min Zeng
Efficacy and Safety of Alprostadil in Microcirculatory Disturbances During Emergency PCI: A Meta-Analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, Beatrice Simeone, Maurizio Forte, Luca D'Ambrosio, Matteo Betti, Alessandra D'Amico, Vittoria Cammisotto, Roberto Carnevale, Simona Bartimoccia, Pierre Sabouret, Giuseppe Biondi Zoccai, Giacomo Frati, Valentina Valenti, Sebastiano Sciarretta, Erica Rocco
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Hong-Fei Wang, Yu-Cheng Mao, Su-Fen Qi, Xin-Yi Xu, Zi-Yan Zhang, Chang Geng, Kai Song, Qing-Bao Tian
Benefits and Risks of Antihyperlipidemic Medication in Adults with Different Low-Density Lipoprotein Cholesterol Based on the Number Needed to Treat. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Dimitrii Khelimskii, Ivan Bessonov, Stanislav Sapozhnikov, Aram Badoyan, Aleksey Baranov, Mahmudov Mamurjon, Serezha Manukian, Ruslan Utegenov, Oleg Krestyaninov
Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)

volume 24, number 5, 2024

Eeshal Fatima, Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Obaid Ur Rehman, Faryal Altaf
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Paolo Severino, Andrea D'Amato, Silvia Prosperi, Marco Valerio Mariani, Vincenzo Myftari, Aurora Labbro Francia, Claudia Cestiè, Elisa Tomarelli, Giovanna Manzi, Lucia Ilaria Birtolo, Stefanie Marek-Iannucci, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Francesco Fedele, Carmine Dario Vizza
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Marwan Sheikh-Taha
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Marco Spagnolo, Claudio Laudani, Antonio Greco, Daniele Giacoppo, Davide Capodanno
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Eeshal Fatima, Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Obaid Ur Rehman, Faryal Altaf
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Stephen R Mandt, Noble Thadathil, Christian Klem, Cristina Russ, Patricia L McNamee, Kevin Stigge, Dong Cheng
Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Jan K Kalinski, Bo Xu, Ramone Boyd, Natalie Tasseff, Katy Rutkowski, Susan Ospina, Nicholas Smedira, Maran Thamilarasan, Zoran B Popovic, Milind Y Desai
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Youssef Soliman, Mohamed Abuelazm, Basma Ehab Amer, Mishaal Hukamdad, Mohamed Hatem Ellabban, Nada Ibrahim Hendi, Adel Mouffokes, Basel AbdelAzeem, Hatem Hassaballa
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Youssef Soliman, Mohamed Abuelazm, Basma Ehab Amer, Mishaal Hukamdad, Mohamed Hatem Ellabban, Nada Ibrahim Hendi, Adel Mouffokes, Basel AbdelAzeem, Hatem Hassaballa
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Marco Spagnolo, Claudio Laudani, Antonio Greco, Daniele Giacoppo, Davide Capodanno
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Jan K Kalinski, Bo Xu, Ramone Boyd, Natalie Tasseff, Katy Rutkowski, Susan Ospina, Nicholas Smedira, Maran Thamilarasan, Zoran B Popovic, Milind Y Desai
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Antonio Greco
Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Antonio Greco
Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Marco Spagnolo, Claudio Laudani, Antonio Greco, Daniele Giacoppo, Davide Capodanno
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Stephen R Mandt, Noble Thadathil, Christian Klem, Cristina Russ, Patricia L McNamee, Kevin Stigge, Dong Cheng
Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F Gellad, Utibe R Essien, Jared W Magnani, Inmaculada Hernandez
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Eeshal Fatima, Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Obaid Ur Rehman, Faryal Altaf
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Paolo Severino, Andrea D'Amato, Silvia Prosperi, Marco Valerio Mariani, Vincenzo Myftari, Aurora Labbro Francia, Claudia Cestiè, Elisa Tomarelli, Giovanna Manzi, Lucia Ilaria Birtolo, Stefanie Marek-Iannucci, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Francesco Fedele, Carmine Dario Vizza
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Jan K Kalinski, Bo Xu, Ramone Boyd, Natalie Tasseff, Katy Rutkowski, Susan Ospina, Nicholas Smedira, Maran Thamilarasan, Zoran B Popovic, Milind Y Desai
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Paolo Severino, Andrea D'Amato, Silvia Prosperi, Marco Valerio Mariani, Vincenzo Myftari, Aurora Labbro Francia, Claudia Cestiè, Elisa Tomarelli, Giovanna Manzi, Lucia Ilaria Birtolo, Stefanie Marek-Iannucci, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Francesco Fedele, Carmine Dario Vizza
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Paolo Severino, Andrea D'Amato, Silvia Prosperi, Marco Valerio Mariani, Vincenzo Myftari, Aurora Labbro Francia, Claudia Cestiè, Elisa Tomarelli, Giovanna Manzi, Lucia Ilaria Birtolo, Stefanie Marek-Iannucci, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Francesco Fedele, Carmine Dario Vizza
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Jan K Kalinski, Bo Xu, Ramone Boyd, Natalie Tasseff, Katy Rutkowski, Susan Ospina, Nicholas Smedira, Maran Thamilarasan, Zoran B Popovic, Milind Y Desai
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Antonio Greco
Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Youssef Soliman, Mohamed Abuelazm, Basma Ehab Amer, Mishaal Hukamdad, Mohamed Hatem Ellabban, Nada Ibrahim Hendi, Adel Mouffokes, Basel AbdelAzeem, Hatem Hassaballa
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Youssef Soliman, Mohamed Abuelazm, Basma Ehab Amer, Mishaal Hukamdad, Mohamed Hatem Ellabban, Nada Ibrahim Hendi, Adel Mouffokes, Basel AbdelAzeem, Hatem Hassaballa
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F Gellad, Utibe R Essien, Jared W Magnani, Inmaculada Hernandez
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Marwan Sheikh-Taha
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Stephen R Mandt, Noble Thadathil, Christian Klem, Cristina Russ, Patricia L McNamee, Kevin Stigge, Dong Cheng
Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)